M. Morel

Interaction of Double-stranded RNA-dependent Protein Kinase (PKR) with the Death Receptor Signaling Pathway in Amyloid β (Aβ)-treated Cells and in APPSLPS1 Knock-in Mice*

M. Paccalin, R. Pontcharraud, B. Fauconneau, 2009, The Journal of Biological Chemistry.

PKR, the double stranded RNA-dependent protein kinase as a critical target in Alzheimer's disease

M. Paccalin, G. Page, C. Lafay-Chebassier, 2009, Journal of cellular and molecular medicine.

Evidence of molecular links between PKR and mTOR signalling pathways in Aβ neurotoxicity: Role of p53, Redd1 and TSC2

M. Paccalin, R. Pontcharraud, B. Fauconneau, 2009, Neurobiology of Disease.

Inhibition of double-stranded RNA-dependent protein kinase strongly decreases cytokine production and release in peripheral blood mononuclear cells from patients with Alzheimer's disease.

M. Paccalin, R. Pontcharraud, B. Fauconneau, 2010, Journal of Alzheimer's disease : JAD.

EphrinA5 protein distribution in the developing mouse brain

M. Jaber, G. Page, A. Gaillard, 2010, BMC Neuroscience.

Prevention of the β-amyloid peptide-induced inflammatory process by inhibition of double-stranded RNA-dependent protein kinase in primary murine mixed co-cultures

F. Terro, M. Paccalin, R. Pontcharraud, 2011, Journal of Neuroinflammation.